Adrian Salmon

Adrian Salmon has 5 years of professional experience. In 2021, they began working as a Research Specialist I at Elixirgen Therapeutics, Inc. Prior to that, they were a Regulatory Affairs Specialist II at Abbott from 2016-2021. Before that, they were a Research Intern at NTT Basic Research Laboratories from 2014-2016.

Adrian Salmon obtained a Bachelor of Science degree in Biomedical/Medical Engineering from the Georgia Institute of Technology in 2015. Adrian then went on to pursue a Master's degree in Biotechnology at The Johns Hopkins University, which they are expected to complete in 2022.